191 related articles for article (PubMed ID: 33193346)
21. Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection.
Groeger D; Schiavi E; Grant R; Kurnik-Łucka M; Michalovich D; Williamson R; Beinke S; Kiely B; Akdis CA; Hessel EM; Shanahan F; O' Mahony L
EBioMedicine; 2020 Oct; 60():102981. PubMed ID: 32927273
[TBL] [Abstract][Full Text] [Related]
22. Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity.
Kim ED; Han SJ; Byun YH; Yoon SC; Choi KS; Seong BL; Seo KY
PLoS One; 2015; 10(9):e0137608. PubMed ID: 26355295
[TBL] [Abstract][Full Text] [Related]
23. IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia.
Aoyagi T; Newstead MW; Zeng X; Kunkel SL; Kaku M; Standiford TJ
Mucosal Immunol; 2017 Jul; 10(4):1043-1055. PubMed ID: 27966554
[TBL] [Abstract][Full Text] [Related]
24. Induction of heterosubtypic immunity to influenza virus by intranasal immunization.
Quan FS; Compans RW; Nguyen HH; Kang SM
J Virol; 2008 Feb; 82(3):1350-9. PubMed ID: 18032492
[TBL] [Abstract][Full Text] [Related]
25. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization.
Marshall D; Sealy R; Sangster M; Coleclough C
J Immunol; 1999 Nov; 163(9):4673-82. PubMed ID: 10528164
[TBL] [Abstract][Full Text] [Related]
26. An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine.
Lee YS; Lee KA; Lee JY; Kang MH; Song YC; Baek DJ; Kim S; Kang CY
Vaccine; 2011 Jan; 29(3):417-25. PubMed ID: 21087689
[TBL] [Abstract][Full Text] [Related]
27. Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge.
Nelson SA; Dileepan T; Rasley A; Jenkins MK; Fischer NO; Sant AJ
J Virol; 2021 Jul; 95(16):e0084121. PubMed ID: 34076479
[TBL] [Abstract][Full Text] [Related]
28. Immunodeficient mouse models in the characterization of the protective immunity to influenza virus.
Bot A; Isobe H; Bona C
Folia Microbiol (Praha); 1998; 43(5):477-8. PubMed ID: 9821301
[No Abstract] [Full Text] [Related]
29. A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system.
Youn HJ; Ko SY; Lee KA; Ko HJ; Lee YS; Fujihashi K; Boyaka PN; Kim SH; Horimoto T; Kweon MN; Kang CY
Vaccine; 2007 Jul; 25(28):5189-98. PubMed ID: 17548137
[TBL] [Abstract][Full Text] [Related]
30. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge.
Galarza JM; Latham T; Cupo A
Viral Immunol; 2005; 18(1):244-51. PubMed ID: 15802970
[TBL] [Abstract][Full Text] [Related]
31. Intranasal co-administration of 1,8-cineole with influenza vaccine provide cross-protection against influenza virus infection.
Li Y; Xu YL; Lai YN; Liao SH; Liu N; Xu PP
Phytomedicine; 2017 Oct; 34():127-135. PubMed ID: 28899494
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
[TBL] [Abstract][Full Text] [Related]
33. Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus.
Rajesh Kumar S; Syed Khader SM; Kiener TK; Szyporta M; Kwang J
PLoS One; 2013; 8(6):e63856. PubMed ID: 23762234
[TBL] [Abstract][Full Text] [Related]
34. IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection.
Arulanandam BP; Raeder RH; Nedrud JG; Bucher DJ; Le J; Metzger DW
J Immunol; 2001 Jan; 166(1):226-31. PubMed ID: 11123296
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells.
Longhi MP; Wright K; Lauder SN; Nowell MA; Jones GW; Godkin AJ; Jones SA; Gallimore AM
PLoS Pathog; 2008 Feb; 4(2):e1000006. PubMed ID: 18389078
[TBL] [Abstract][Full Text] [Related]
36. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.
Bot A; Antohi S; Bot S; Garcia-Sastre A; Bona C
Int Immunol; 1997 Nov; 9(11):1641-50. PubMed ID: 9418125
[TBL] [Abstract][Full Text] [Related]
37. Protective antibody responses against A(H1N1)pdm09 primed by infection and recalled by intranasal vaccination.
Ikeda K; Ainai A; Hasegawa H
Vaccine; 2015 Nov; 33(45):6066-9. PubMed ID: 26432916
[TBL] [Abstract][Full Text] [Related]
38. Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.
Wang Z; Chua BY; Ramos JV; Parra SM; Fairmaid E; Brown LE; Jackson DC; Kedzierska K
Vaccine; 2015 Sep; 33(39):5148-54. PubMed ID: 26277069
[TBL] [Abstract][Full Text] [Related]
39. Tissue Distribution of Memory T and B Cells in Rhesus Monkeys following Influenza A Infection.
Pichyangkul S; Yongvanitchit K; Limsalakpetch A; Kum-Arb U; Im-Erbsin R; Boonnak K; Thitithayanont A; Jongkaewwattana A; Wiboon-ut S; Mongkolsirichaikul D; Mahanonda R; Spring M; Chuang I; Mason CJ; Saunders DL
J Immunol; 2015 Nov; 195(9):4378-86. PubMed ID: 26408671
[TBL] [Abstract][Full Text] [Related]
40. Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses.
Sasaki E; Asanuma H; Momose H; Furuhata K; Mizukami T; Hamaguchi I
PLoS Pathog; 2021 Aug; 17(8):e1009890. PubMed ID: 34460865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
